{"name":"Advanced-J","slug":"advanced-j","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Angiotensin II receptor antagonists, Calcium channel blocker","genericName":"Angiotensin II receptor antagonists, Calcium channel blocker","slug":"angiotensin-ii-receptor-antagonists-calcium-channel-blocker","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"Angiotensin II receptor antagonists, Calcium channel blocker","genericName":"Angiotensin II receptor antagonists, Calcium channel blocker","slug":"angiotensin-ii-receptor-antagonists-calcium-channel-blocker","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxOWUlDMnRwdXZPdEtzOFdQYVBpdWFqcV83OTRCU3dMQXkzT1duQTVNb09ZdTdpUUp2aTUtV3Jld25kMnByZkpDSzN5OHV6d0JxYUZqX2psN1paX1JFR3lsSVpaeWdOakZBZGhhOG82WXpxYkpEZTJEdFV2UEV5Q3Q0SXV6U2RNODktY1RfdS0wTFV3b1IzZW5UbjBMbzllZw?oc=5","date":"2026-02-19","type":"pipeline","source":"PharmaTimes","summary":"Lario Therapeutics awarded $2.4m to advance calcium channel platform - PharmaTimes","headline":"Lario Therapeutics awarded $2.4m to advance calcium channel platform","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxPZzZLWjVxT0FZUDdKRU96WGdqUS1ETEZacXBEQmxUTTFrUEdBRWl0SDI3M250eFZSY0hZRF9rMzA0MUJZdVJmS1Z4NVM1VjNQUW5DX1BjQUxRbFh1SXFyaHVkaFVkb3Vmc1RTM1QtUzB0UzMtdTlsektBU01YenVkbmZDejdlZFlpVWw0d2F3MU03YmZPQkl3LVdkRFhqUFFha1RPNlk4bkpaSXdVU2hPTGtmMW4?oc=5","date":"2026-02-04","type":"pipeline","source":"pharmaceutical-journal.com","summary":"Preceptorship: the key to unlocking advanced pharmacist practice - pharmaceutical-journal.com","headline":"Preceptorship: the key to unlocking advanced pharmacist practice - pharmaceutical","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxNYndfSVB6SnEtVHE4d2JzNl9mbWx5S0k1RjZYVV9mQmwzQXFXTEx6elRzbDBkWEhxSGpTX1Z6eHRreC00dU5lVFkwNlIyNmMyT2VXMm5ZSkFPX0lIV1NiT1NsVDlpd3htc002eGNncDJrRnlkVFY1RjBzcjhjTzJhNGQ2UmtWZw?oc=5","date":"2026-01-13","type":"deal","source":"Procurement Magazine","summary":"How J&J’s Deal with Trump will Reshape Pharma Value Chain - Procurement Magazine","headline":"How J&J’s Deal with Trump will Reshape Pharma Value Chain","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTE5kMVFfeHQwanJxUTVGMlZRblA5UUk2M2dRRjl0YmVjSldYTy16UWp4a2JNN1JXaVNLS2cxaXI3LWJnT0QxdTYzSnJuUjc5WmhzS2tnMnh2dF9fRXVyQzEycUxaZmFyQ25hMEg3NUthd29MT0xXMEhj?oc=5","date":"2025-12-16","type":"trial","source":"Oncology Pipeline","summary":"J-Pharma chases Telix in LAT1 | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline","headline":"J-Pharma chases Telix in LAT1 | ApexOnco - Clinical Trials news and analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYEFVX3lxTE9sbG1Ya0ZkSWdha0dLVWExLWVjc0JqR2huUEJDbURQUFh3TXNqS0ZVYU94eWJ5NUJlM1NqbktjY0pyT2ZyS3pnM2hCUmFWVDFpU09RWXo5dzJFMWdCVXdVbQ?oc=5","date":"2025-10-19","type":"pipeline","source":"NEJM","summary":"Sacituzumab Govitecan in Untreated, Advanced Triple-Negative Breast Cancer - NEJM","headline":"Sacituzumab Govitecan in Untreated, Advanced Triple-Negative Breast Cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxPZHBhZEJyYjNPbmwwdDZHY05HTnZFQ0xScHZFYzJHSkJkbDk3R2w4ZS1sei1HRHFQX3BaTXE3ZHBUaElSTzFjdHdpV25OOVU0b3h1WDNHZ2Rud3NPRWI5WnNlSUFxVWVGWURXOXBLd3dMUGMwc1RTcEFRd2tvUUJSX3hqSThfUThXMGdQcTk5NFc4TlJlS1JxVVZGZS1TVlFJOVFKaWNVLWJ2T1FiY1ZwT0lPcUIyQjhvVE5z?oc=5","date":"2025-10-05","type":"pipeline","source":"PharmTech.com","summary":"Predictive Modeling for Small-Molecule Formulation Development Using Advanced Algorithms - PharmTech.com","headline":"Predictive Modeling for Small-Molecule Formulation Development Using Advanced Algorithms","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-09-17","type":"pipeline","source":"fortuneindia.com","summary":"Mankind joins hands with OpenAI to integrate advanced AI into core operations - fortuneindia.com","headline":"Mankind joins hands with OpenAI to integrate advanced AI into core operations","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxON2E4TVVSbTBvX05McFBjRjZtRXVaNmc0VjdjVC01OE56MzBpN1NCU0Z6R2pZLV9GenM1Q3FWcmdTREJXY3dqYTJFaW1zc2dlaXN4NXVFbHBWVVNBU0VaWGxSWlBzRHczc09EQUN5b295MEUyaGViMmZYTmtwZmtqSUpEUFh2eXZEMVAwbE1ZQ2FpaFVG?oc=5","date":"2025-09-15","type":"trial","source":"Frontiers","summary":"Technological and industrial trends in China’s pharmaceutical sector - Frontiers","headline":"Technological and industrial trends in China’s pharmaceutical sector","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFBpSHM2YlhaVUVnYnNpTndYdkpqbzVzN19xSU5RX2pIeVkyRUtZNWEtTmxBU0plWDJSZVJpVkh4Q0VBQkZockdDaGtjSVlqT2NKLUl3VUJYeHBZVzNhcmU4?oc=5","date":"2025-03-05","type":"pipeline","source":"Nature","summary":"Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines - Nature","headline":"Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxPQWhaUVhfY2tfcE5mZjJYQTRXNWJmaGdhSkc5LUdUMXNFQjZyNFJISXZXdWdTTDNSN2JQQ01kWTRZdzVpaTk3Z3Z6TWpvZ2RGczJTTnhFNVpRdG1JMV9hM2ZnTXp4MXFOclh4akZGbGtKSU9hd1NOQmZOa1RUNVJ0dkM4SHdsU1NjMjJILTJ2enk?oc=5","date":"2025-01-08","type":"pipeline","source":"ScienceDirect.com","summary":"Journal of Pharmaceutical Analysis | Vol 15, Issue 1, January 2025 - ScienceDirect.com","headline":"Journal of Pharmaceutical Analysis | Vol 15, Issue 1, January 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4wFBVV95cUxOOF9odEJieWJ0LWliMHcyZDFxUWtKZVctV1hBWUZxOFBzX0RmdE9idlAyTlRmR2FTcTVKQUc5TWU0OGJ0YUl1YllBX2N4M1djQmhrbWhmcll2NElmd0N5bEF0LUdxaWxDeEFjaUhKWmlhQ1hZd2NnV0hLWkd2UF9YdU4takJBQXlwX3dlS0F4OUVITzZsdjVXVUN0a2UtVnM4U25ZYkN2WGNaRlo0Vm9GS3U0QTA5SjFzZlpZbUZOajh0b2hUYW5oVW93bXlISkRoRy1va0ZkMEswTDNfaS1WMmI3VQ?oc=5","date":"2024-11-14","type":"pipeline","source":"PR Newswire","summary":"Bexion Pharmaceuticals, Inc. Awarded Grant from The Michael J. Fox Foundation to Advance BXQ-350 - PR Newswire","headline":"Bexion Pharmaceuticals, Inc. Awarded Grant from The Michael J. Fox Foundation to Advance BXQ-350","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTE92U21uR0RMQ05DQnZKRkl5eXR6elpmb0hlWUdwWVUta3hmRkFVbE1mN3QxbHYwZ2dYc1RkNmJRUk1wbU5XT2tleU5KY0ZlSlpKbHQtcXFYUlRhc0lyVGVkVWFYTkt3cTkyeVRpenJ6bnVwY01mR2pZ?oc=5","date":"2024-10-10","type":"pipeline","source":"Johnson & Johnson","summary":"6 ways Johnson & Johnson is using AI to help advance healthcare - Johnson & Johnson","headline":"6 ways Johnson & Johnson is using AI to help advance healthcare - Johnson & Johnson","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}